课题基金 / 基金详情

Development of the next generation radiation therapy based on molecular imaging

Development of the next generation radiation therapy based on molecular imaging
基于分子成像的下一代放射治疗的发展
批准号:
22591392
负责人:
NISHIMURA Yasumasa
金额:
$2.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012

项目摘要

项目成果

NISHIMURA Yasumasa的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To visualize intratumoral hypoxic areas and their reoxygenation before and during fractionated radiation therapy (RT), 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) were performed. Ten patients, consisting of four head and neck cancers, four gastrointestinal cancers, one lung cancer, and one uterine cancer, were included. F-MISO PET/CT was performed twice before RT and during fractionated RT of approximately 20 Gy/10 fractions for eight of the 10 patients. F-MISO maximum standardized uptake values (SUVmax) of normal muscles and tumors were measured. The tumor-to-muscle (T/M) ratios of F-MISO SUVmax were also calculated. Mean SUVmax ± standard deviation (SD) of normal muscles was 1.25 ± 0.17, and SUVmax above the mean + 2 SD (≧1.60 SUV) was regarded as a hypoxic area. Nine of the 10 tumors had an F-MISO SUVmax of equal to or more than 1.60. All eight tumors examined twice showed a decrease in SUVmax, T/M ratio, or percentage of hypoxic volume (F-MISO ≧1.60) at approximately 20 Gy, indicating reoxygenation. In conclusion, accumulation of F-MISO of ≧1.60 SUV was regarded as an intratumoral hypoxic area in our F-MISO PET/CT system. Most human tumors (90%) in this small series had hypoxic areas before RT, although hypoxic volume was minimal (0.0-0.3%) for four of the 10 tumors. In addition, reoxygenation was observed in most tumors at two weeks of the fractionated RT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Takashi Imai, Atsuko Ishikawa, Tomo Suga, Yoshimi Shoji, Nishimura Y]
通讯作者: Nishimura Y
DOI: 10.1093/jjco/hyp136
发表时间: 2010-02-01
期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY
影响因子: 2.4
作者: [Nishimura, Yasumasa, Shibata, Toru, Okumura, Masahiko]
通讯作者: Okumura, Masahiko
DOI: 10.1007/s10147-011-0254-y
发表时间: 2012-02-01
期刊: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
影响因子: 3.3
作者: [Nishimura, Yasumasa, Koike, Ryuta, Tamamoto, Tetsuro]
通讯作者: Tamamoto, Tetsuro
a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer
一种针对表皮生长因子受体的新型单克隆抗体,用于治疗非小细胞肺癌
DOI: --
发表时间: 2011
期刊: Lung Cancer: Targets and Therapy
影响因子: --
作者: [Takeda M, Okamoto I, Nishimura Y, Nakagawa K. Nimotuzumab]
通讯作者: Nakagawa K. Nimotuzumab
24
    Organ-specific tolerance doses in intensity-modulated radiation therapy for head and neck cancer
    • 批准号:
      20K08009
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2020
    • 负责人:
      NISHIMURA Yasumasa
    • 依托单位:
    Adaptive radiation therapy based on in-room CT image
    • 批准号:
      16K10406
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2016
    • 负责人:
      NISHIMURA Yasumasa
    • 依托单位:
    High precision radiation therapy based on intra-tumoral hypoxic imaging
    • 批准号:
      25461932
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2013
    • 负责人:
      NISHIMURA Yasumasa
    • 依托单位:
    Clinical studies on the simultaneous integrated boost method using intensity modulated radiotherapy (IMRT)
    • 批准号:
      17591300
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.43万
    • 财政年份:
      2005
    • 负责人:
      NISHIMURA Yasumasa
    • 依托单位:
    国内基金
    海外基金
    基于影像-病理-空间多组学的放射性碘难治性甲状腺癌早期预测及生物学机制研究
    • 批准号:
      ZCLQN26H1801
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      魏培英
    • 依托单位:
    生物学可解释的人工智能预测食管鳞癌化疗联合免疫治疗疗效
    • 批准号:
      JCZRLH202601123
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    睾丸引带发育分子调控机制及类器官重建
    • 批准号:
      JCZRLH202601476
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    人类活动对鄂东地区主要湖泊福寿螺入侵风险和系统发生影响的研究
    • 批准号:
      JCZRLH202600034
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: